Results 101 to 110 of about 11,700 (225)

Effect of treatment with carteolol and latanoprost in newly diagnosed primary open-angle glaucoma on peripapillary vessel density

open access: yesBiomedical Papers
Background and Aim. In a previous follow-up of glaucoma patients taking carteolol or latanoprost, we found a greater progression of visual field changes with the prostaglandin than the betablocker. In the present study we compared the impact of carteolol
Lestak Jan, Fus Martin, Pitrova Sarka
doaj   +1 more source

Omidenepag Isopropyl 0.002% versus Latanoprost 0.005% in Open-Angle Glaucoma/Ocular Hypertension: The Randomized Phase III PEONY Trial

open access: yesClinical Ophthalmology
Tsing Hong Wang,1 Tin Aung,2– 4 Da-Wen Lu,5 Ronnie George,6 Sirisha Senthil,7 Fenghe Lu,8 Noriko Odani-Kawabata,9 Ki Ho Park10 1Department of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan; 2Singapore Eye Research Institute, Singapore
Wang TH   +7 more
doaj  

Latanoprost

open access: hybrid, 2020
National Cancer Institute
openalex   +1 more source

Efficacy and Tolerability of a New Latanoprost 0.005% BAK-Free Nanoemulsion: A Nonrandomized Open-Label Trial

open access: gold, 2021
Javier Fernando Casiraghi   +4 more
openalex   +1 more source

Estudio de la inervación corneal y la unidad funcional lagrimal en pacientes tratados con Latanoprost en colirio monodosis [PDF]

open access: yes, 2016
El tractament mèdic crònic és la primera opció per tractar el glaucoma primari d'angle obert (GPAA) i la hipertensió ocular (OH). L'objectiu d'aquest estudi va ser avaluar els efectes del latanoprost sense conservant en les característiques de la pel ...
Cortà Fumei, Andrea da
core   +1 more source

Evaluation of frequency doubling perimetry in ocular hypertone [PDF]

open access: yes, 2000
Fossarello, M   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy